S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% BITCOIN 64,574.68 -0.34%

S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% BITCOIN 64,574.68 -0.34%

Next Bullish Trade

Sign in

Account

Create free accountFree dashboard, no payment Sign inEmail yourself a login link CoursesYour library & catalog

NVZMY

Novozymes A/S PNK · NVZMY

$64.82 -0.70 (-1.07%)

Neutral · +1.00σ Grade C

+ Compare Open in Sniper

News · NVZMY

Full news feed →

Novonesis delivered strong start to the year with 7% organic sales growth in Q1

GlobeNewswire Inc. · 75d ago

Interim report Q1 2026

GlobeNewswire Inc. · 75d ago

Arla Foods Ingredients Menyasarkan Pemakanan Sokongan GLP-1 di Vitafoods Europe

GlobeNewswire Inc. · 94d ago

Novonesis expands global footprint with acquisition of production facility in Southeast Asia

Benzinga · 102d ago

Novonesis issues EUR 1.7 billion senior unsecured notes

GlobeNewswire Inc. · 128d ago

Agricultural Microbial Market Report 2026: $15.5+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

GlobeNewswire Inc. · 172d ago

Bread Improvers Market Size to Exceed USD 2.92 Billion by 2035, Driven by Clean-Label, Functional Baking, and AI-Enabled Formulation

GlobeNewswire Inc. · 191d ago

Major shareholder announcement

GlobeNewswire Inc. · 253d ago

Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters

GlobeNewswire Inc. · 285d ago

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

GlobeNewswire Inc. · 314d ago

Trading by management and close relations of management

GlobeNewswire Inc. · 330d ago

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%

GlobeNewswire Inc. · 332d ago

Interim report H1 2025

GlobeNewswire Inc. · 332d ago

2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement

GlobeNewswire Inc. · 332d ago

Transactions under Novonesis’ share buyback program

GlobeNewswire Inc. · 411d ago

Combining EVP roles of Human Health Biosolutions and Strategy & Integration

GlobeNewswire Inc. · 425d ago

Initiation of share buyback program

GlobeNewswire Inc. · 501d ago

12M 2024 Company announcement

GlobeNewswire Inc. · 508d ago

Specialty Enzymes Market to Expand at 7.5% CAGR, Reaching USD 10.7 Billion by 2032 | SNS Insider

GlobeNewswire Inc. · 513d ago

Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance

GlobeNewswire Inc. · 523d ago

New employee-elected board member

GlobeNewswire Inc. · 635d ago

MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?

Zacks Investment Research · 822d ago

Is CalMaine Foods (CALM) Stock Outpacing Its Basic Materials Peers This Year?

Zacks Investment Research · 835d ago